Symphogen
Haldis Mønsted has a diverse work experience spanning various roles and industries. Haldis has worked as a Laboratory Technician in the Antibody Discovery Team at Symphogen since November 2017. Prior to that, they worked as a Forskningslaborant at Finsen Laboratory (Bo Porse group) from January 2015 to October 2017. From February 2006 to December 2014, they worked as a Forskningslaborant at Finsen Laboratory (Michael Ploug group), where their responsibilities included PCR, Rolling circle mutagenese, kloning, DNA oprensning med kit, transfektion af forskellige kompetente celler, fremstilling af buffer, agarose geler og håndtering af dem.
Haldis also has previous experience as a Laborantelev at Københavns Universitet from 2005 to 2006, where they were involved in research projects related to the interaction between insects and microorganisms. Prior to working in research, they gained experience in the manufacturing industry, working as a Fabriksarbejder at Reje og skaldyrsfabrik, P/F Joensen, Oyri, Færøerne from 2002 to 2003 and at Saltfiskfabrik, P/F FARITA, Haldórsvík, Færøerne from 2001 to 2002.
Haldis Mønsted attended Kambsdalur, Eysturoy, Færøerne from 2000 to 2002, where they obtained a HF degree. Following this, they enrolled at EUC Vest, Esbjerg from 2003 to 2005 and completed a degree as a Laborant. No specific field of study is mentioned for either degree.
This person is not in any offices
Symphogen
3 followers
Symphogen is a clinical-stage antibody oncology focused company with a differentiated product pipeline and significant commercial opportunities. Inspired by nature, led by science and driven by people, we passionately strive to make that discovery that may have great effect on the lives of patients, their families, and their caregivers. Based on our monoclonal antibody (mAb) research platform, we create differentiated mAb and mAb mixture products candidates. Our pre-clinical and clinical pipeline is well suited for a precision-medicine approach by addressing well-defined, biomarker-selected patient populations. We are headquartered in Denmark with operations in the US.